Welch & Forbes’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-5
| Closed | -$52K | – | 372 |
|
|
2018
Q1 | $52K | Hold |
5
| – | – | ﹤0.01% | 355 |
|
|
2017
Q4 | $78K | Sell |
5
-14
| -74% | -$218K | ﹤0.01% | 337 |
|
|
2017
Q3 | $504K | Sell |
19
-2
| -10% | -$53.1K | 0.01% | 240 |
|
|
2017
Q2 | $1.08M | Sell |
21
-6
| -22% | -$309K | 0.03% | 190 |
|
|
2017
Q1 | $2.06M | Sell |
27
-11
| -29% | -$839K | 0.06% | 162 |
|
|
2016
Q4 | $2.98M | Sell |
38
-15
| -28% | -$1.18M | 0.09% | 140 |
|
|
2016
Q3 | $6.82M | Buy |
53
+1
| +2% | +$129K | 0.24% | 98 |
|
|
2016
Q2 | $5.66M | Buy |
52
+2
| +4% | +$218K | 0.17% | 113 |
|
|
2016
Q1 | $6.58M | Buy |
50
+2
| +4% | +$263K | 0.2% | 109 |
|
|
2015
Q4 | $6.5M | Buy |
48
+7
| +17% | +$947K | 0.21% | 109 |
|
|
2015
Q3 | $6.67M | Hold |
41
| – | – | 0.22% | 103 |
|
|
2015
Q2 | $12.5M | Buy |
+41
| New | +$12.5M | 0.39% | 76 |
|